- Home
- JG vs SAVA Comparison
JG vs SAVA Comparison
Compare JG & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- SAVA
- Stock Information
- Founded
- JG 2012
- SAVA 1998
- Country
- JG China
- SAVA United States
- Employees
- JG N/A
- SAVA N/A
- Industry
- JG Computer Software: Programming Data Processing
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- JG Technology
- SAVA Health Care
- Exchange
- JG Nasdaq
- SAVA Nasdaq
- Market Cap
- JG 67.2M
- SAVA 70.5M
- IPO Year
- JG 2018
- SAVA N/A
- Fundamental
- Price
- JG $10.99
- SAVA $1.99
- Analyst Decision
- JG
- SAVA Buy
- Analyst Count
- JG 0
- SAVA 2
- Target Price
- JG N/A
- SAVA $54.50
- AVG Volume (30 Days)
- JG 18.9K
- SAVA 1.1M
- Earning Date
- JG 08-28-2025
- SAVA 08-07-2025
- Dividend Yield
- JG N/A
- SAVA N/A
- EPS Growth
- JG N/A
- SAVA N/A
- EPS
- JG N/A
- SAVA N/A
- Revenue
- JG $46,938,193.00
- SAVA N/A
- Revenue This Year
- JG $10.90
- SAVA N/A
- Revenue Next Year
- JG N/A
- SAVA N/A
- P/E Ratio
- JG N/A
- SAVA N/A
- Revenue Growth
- JG 17.73
- SAVA N/A
- 52 Week Low
- JG $2.36
- SAVA $1.15
- 52 Week High
- JG $20.94
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- JG 55.95
- SAVA 53.30
- Support Level
- JG $10.30
- SAVA $1.76
- Resistance Level
- JG $12.80
- SAVA $2.17
- Average True Range (ATR)
- JG 0.73
- SAVA 0.10
- MACD
- JG -0.03
- SAVA -0.01
- Stochastic Oscillator
- JG 43.45
- SAVA 61.90
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.